}}Coronavirus disease 2019 – United Perfonmance

United Perfonmance

  • Home
  • Company
  • It Solutions
  • Capability Statement
  • Contact

Coronavirus disease 2019

jueves, 23 abril 2026 / Publicado en Public

Coronavirus disease 2019

COVID-19 is a contagious disease caused by the coronavirus SARS-CoV-2. In January 2020, the disease spread worldwide, resulting in the COVID-19 pandemic.

The symptoms of COVID‑19 can vary but often include fever,[7] fatigue, cough, breathing difficulties, loss of smell, and loss of taste.[8][9][10] Symptoms may begin one to fourteen days after exposure to the virus. At least a third of people who are infected do not develop noticeable symptoms.[11][12] Of those who develop symptoms noticeable enough to be classified as patients, most (81%) develop mild to moderate symptoms (up to mild pneumonia), while 14% develop severe symptoms (dyspnea, hypoxia, or more than 50% lung involvement on imaging), and 5% develop critical symptoms (respiratory failure, shock, or multiorgan dysfunction).[13] Older people have a higher risk of developing severe symptoms. Some complications result in death. Some people continue to experience a range of effects (long COVID) for months or years after infection, and damage to organs has been observed.[14] Multi-year studies on the long-term effects are ongoing.[15]

COVID‑19 transmission occurs when infectious particles are breathed in or come into contact with the eyes, nose, or mouth. The risk is highest when people are in close proximity, but small airborne particles containing the virus can remain suspended in the air and travel over longer distances, particularly indoors. Transmission can also occur when people touch their eyes, nose, or mouth after touching surfaces or objects that have been contaminated by the virus. People remain contagious for up to 20 days and can spread the virus even if they do not develop symptoms.[16]

Testing methods for COVID-19 to detect the virus’s nucleic acid include real-time reverse transcription polymerase chain reaction (RT‑PCR),[17][18] transcription-mediated amplification,[17][18][19] and reverse transcription loop-mediated isothermal amplification (RT‑LAMP)[17][18] from a nasopharyngeal swab.[20]

Several COVID-19 vaccines have been approved and distributed in various countries, many of which have initiated mass vaccination campaigns. Other preventive measures include physical or social distancing, quarantining, ventilation of indoor spaces, use of face masks or coverings in public, covering coughs and sneezes, hand washing, and keeping unwashed hands away from the face. While drugs have been developed to inhibit the virus, the primary treatment is still symptomatic, managing the disease through supportive care, isolation, and experimental measures.

What you can read next

Die historische Entwicklung des Glücksspiels Ein Überblick über die wichtigsten Meilensteine
Sichere Einzahlungen im Run4Win Casino: Deine Daten in besten Händen
Prácticas responsables en juegos de casino cómo Marca Apuestas Casino promueve la seguridad del jugador

Search for posts

Recent Posts

  • Dans la situation des casinos en ligne, Paysafecard se pose comme un fleur aide pour de nombreuses personnes possibilites

    0 comments
  • Pas vrai, toi-meme negatif n’avez tenter un atout sans avoir de conserve exclusive que la bizarre soir

    0 comments
  • Et ce, quel constitue the best salle de jeu du orbite a l�egard de retrogradation inherent des francais ?

    0 comments

Recent Comments

  • A WordPress Commenter en Hello world!

SITE

  • Home
  • Company
  • It Solutions
  • Capability Statement
  • Contact

IT SOLUTIONS

  • VOICE / DATA SOLUTIONS
  • FIBER OPTIC INSTALLATION
  • AISLE CONTAINMENT SYSTEMS
  • DATA CENTERS
  • AV SYSTEM

CONTACT

Monday - Friday 8:30am - 05:00pm

(703) 296-2251

info@upcincorp.com

CAPABILITY STATEMENT PDF

© UPC - Design by OMNI Agencia de Marketing Digital

SUBIR